Patricia Franchi

Outcome of patients older than 60 years with classical Hodgkin lymphoma treated with front line <scp>ABVD</scp> chemotherapy: frequent pulmonary events suggest limiting the use of bleomycin in the elderly

Aspasia Stamatoullas, Pauline Brice, Réda Bouabdallah et al. · British Journal of Haematology · 2015 · 85 citations · Full text

Medicine, Oncology, Pharmacology +17

Rituximab, Dexamethasone, Cytarabine, and Oxaliplatin (R-DHAX) Is an Effective and Safe Salvage Regimen in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Julie Lignon, David Sibon, Isabelle Madelaine et al. · Clinical Lymphoma Myeloma & Leukemia · 2010 · 59 citations

Medicine, Oncology, Pharmacotherapy +13

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma

Soledad Henriquez, Jérémie Zerbit, Timothée Bruel et al. · Blood · 2021 · 49 citations · Full text

Medicine, Immunology, Oncology +17

Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron Era

Jérémie Zerbit, Marion Detroit, Antoine Meyer et al. · Viruses · 2022 · 30 citations · Full text

Medicine, Hematology, Immunology +17

Prognostic value of early 18F-FDG PET scanning evaluation in immunocompetent primary CNS lymphoma patients

Rudy Birsen, Estelle Blanc, Lise Willems et al. · Oncotarget · 2018 · 24 citations · Full text

Medicine, Nuclear Medicine, Oncology +17